Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flexadrin is a consumer healthcare and nutraceutical company focused on the development and commercialization of joint health supplements. The company's flagship product line is centered around a proprietary blend of esterified fatty acids, specifically Celadrin, which is designed to reduce inflammation and improve joint mobility. Flexadrin offers its formulations in various delivery formats, including oral capsules and topical creams, targeting patients with osteoarthritis and general joint discomfort. The company operates primarily in the South African market and international retail sectors, positioning itself as a provider of clinically researched natural alternatives for pain management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flexadrin.